Cronos Group Inc. Amends 8-K Filing
Ticker: CRON · Form: 8-K/A · Filed: Jul 22, 2024 · CIK: 1656472
| Field | Detail |
|---|---|
| Company | Cronos Group Inc. (CRON) |
| Form Type | 8-K/A |
| Filed Date | Jul 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, filing-update
Related Tickers: CRON
TL;DR
Cronos Group (CRON) filed an 8-K/A amendment on June 20, 2024, related to shareholder votes. Nothing major changed, just a procedural update.
AI Summary
Cronos Group Inc. filed an 8-K/A on July 22, 2024, to amend a previous filing regarding a submission of matters to a vote of security holders. The earliest event reported in this amendment was on June 20, 2024. The company, previously known as PharmaCan Capital Corp. until October 21, 2015, is incorporated in British Columbia, Canada, with its principal executive offices located in Toronto, Ontario.
Why It Matters
This amendment to a previous filing indicates a procedural update or correction by Cronos Group Inc. regarding matters submitted for a shareholder vote, which could be relevant for investors tracking corporate governance actions.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and does not introduce new material events or financial changes.
Key Players & Entities
- Cronos Group Inc. (company) — Registrant
- PharmaCan Capital Corp. (company) — Former company name
- June 20, 2024 (date) — Earliest event reported date
- July 22, 2024 (date) — Filing date
- October 21, 2015 (date) — Date of name change
- 111 Peter Street, Suite 300 Toronto, Ontario M5V 2H1 (address) — Principal executive offices
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing serves to amend a previous report concerning the submission of matters to a vote of security holders.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 20, 2024.
What was Cronos Group Inc.'s former name?
Cronos Group Inc.'s former name was PharmaCan Capital Corp.
When did Cronos Group Inc. change its name?
The company changed its name from PharmaCan Capital Corp. on October 21, 2015.
Where are Cronos Group Inc.'s principal executive offices located?
Cronos Group Inc.'s principal executive offices are located at 111 Peter Street, Suite 300, Toronto, Ontario M5V 2H1.
Filing Stats: 540 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-07-22 16:32:05
Filing Documents
- cron-20240620.htm (8-K/A) — 28KB
- 0001656472-24-000080.txt ( ) — 164KB
- cron-20240620.xsd (EX-101.SCH) — 2KB
- cron-20240620_def.xml (EX-101.DEF) — 3KB
- cron-20240620_lab.xml (EX-101.LAB) — 24KB
- cron-20240620_pre.xml (EX-101.PRE) — 14KB
- cron-20240620_htm.xml (XML) — 4KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On July 19, 2024, the Company reconvened its 2024 Annual Meeting of Shareholders (the "Meeting"), which was adjourned on June 20, 2024. The proposal voted upon at the reconvened Meeting and the final results of the shareholder vote on the proposal are set forth below. The proposal is summarized in greater detail in the Company's definitive proxy statement on Schedule 14A filed with the SEC on April 26, 2024, as supplemented by the Company's supplement to the definitive proxy statement on Schedule 14A filed with the SEC on July 5, 2024. Proposal No. 3: Appointment of Davidson & Company LLP, the Company's independent registered public accounting firm, to serve as the Company's independent auditor for fiscal year 2024 and to authorize the Board of Directors of the Company to fix the independent auditors' remuneration For Withheld 270,300,960 3,834,201
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CRONOS GROUP INC. Dated: July 22, 2024 By: /s/ Michael Gorenstein Name: Michael Gorenstein Title: President and Chief Executive Officer